Dr Yonas Tegegn Woldemariam, WHO Representative to Uganda, welcomed the country's progress in key healthcare areas.
In this explainer, we lay out why the disease, which can kill up to 50 percent of patients who progress to severe symptoms, ...
The ‘cousin’ of Ebola that leaves its victims in a ‘ghost-like’ state ... according to the World Health Organisation (WHO).
S ubjects at HJF Medical Research International in Nigeriahave received a Lassa fever virus (LASV) vaccine candidate in the ...
"Continued outbreaks of Lassa fever and the emergence of Ebola Sudan in Uganda both underscore the need to have vaccines for ...
Soligenix’s SuVax gets US FDA orphan drug designation for prevention and post-exposure prophylaxis against SUDV infection." Princeton, New Jersey Saturday, April 13, 2024, 09:00 Hrs [IST] ...
In some pet-owning homes in Portugal and the UK, sick pets and their owners were colonized by similar strains of resistant ...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
The government announced Tuesday that the world’s second-largest economy grew at a rate of 5.3% annually from January to ...
Global deployment of rapid diagnostic tests to boost fight against cholera: Geneva Saturday, April 6, 2024, 12:00 Hrs [IST] More than 1.2 million cholera rapid diagnostic tests wi ...
BLANTYRE-(MaraviPost)-The mouth piece for the voiceless, Centre for Democracy and Economic Development Initiatives (CDEDI) ...
"Continued outbreaks of Lassa fever and the emergence of Ebola Sudan in Uganda both underscore the need to have vaccines for known disease threats available for evaluation and use during outbreak ...